These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31772027)

  • 21. Utility of an "Allosteric Site-Impaired" M
    Moo EV; Sexton PM; Christopoulos A; Valant C
    Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function studies of muscarinic acetylcholine receptors.
    Leach K; Simms J; Sexton PM; Christopoulos A
    Handb Exp Pharmacol; 2012; (208):29-48. PubMed ID: 22222693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multitargeting nature of muscarinic orthosteric agonists and antagonists.
    Myslivecek J
    Front Physiol; 2022; 13():974160. PubMed ID: 36148314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.
    Teal LB; Gould RW; Felts AS; Jones CK
    Adv Pharmacol; 2019; 86():153-196. PubMed ID: 31378251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology.
    Wess J
    Trends Pharmacol Sci; 2003 Aug; 24(8):414-20. PubMed ID: 12915051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.
    Haga K; Kruse AC; Asada H; Yurugi-Kobayashi T; Shiroishi M; Zhang C; Weis WI; Okada T; Kobilka BK; Haga T; Kobayashi T
    Nature; 2012 Jan; 482(7386):547-51. PubMed ID: 22278061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-Activity Relationships of Pan-Gα
    Berizzi AE; Bender AM; Lindsley CW; Conn PJ; Sexton PM; Langmead CJ; Christopoulos A
    ACS Chem Neurosci; 2018 Jul; 9(7):1818-1828. PubMed ID: 29683647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Negative Allosteric Modulation of M
    Gould RW; Gunter BW; Bubser M; Matthews RT; Teal LB; Ragland MG; Bridges TM; Garrison AT; Winder DG; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2019 Aug; 10(8):3740-3750. PubMed ID: 31268669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of
    Garrison AT; Orsi DL; Capstick RA; Whomble D; Li J; Carter TR; Felts AS; Vinson PN; Rodriguez AL; Han A; Hajari K; Cho HP; Teal LB; Ragland MG; Ghamari-Langroudi M; Bubser M; Chang S; Schnetz-Boutaud NC; Boutaud O; Blobaum AL; Foster DJ; Niswender CM; Conn PJ; Lindsley CW; Jones CK; Han C
    J Med Chem; 2022 Apr; 65(8):6273-6286. PubMed ID: 35417155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulation of muscarinic acetylcholine receptors.
    Gregory KJ; Sexton PM; Christopoulos A
    Curr Neuropharmacol; 2007 Sep; 5(3):157-67. PubMed ID: 19305798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).
    Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.
    Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C
    Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
    Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
    J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location.
    Foster DJ; Gentry PR; Lizardi-Ortiz JE; Bridges TM; Wood MR; Niswender CM; Sulzer D; Lindsley CW; Xiang Z; Conn PJ
    J Neurosci; 2014 Feb; 34(9):3253-62. PubMed ID: 24573284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
    Leach K; Loiacono RE; Felder CC; McKinzie DL; Mogg A; Shaw DB; Sexton PM; Christopoulos A
    Neuropsychopharmacology; 2010 Mar; 35(4):855-69. PubMed ID: 19940843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscarinic M5 receptors trigger acetylcholine-induced Ca
    Zuccolo E; Laforenza U; Negri S; Botta L; Berra-Romani R; Faris P; Scarpellino G; Forcaia G; Pellavio G; Sancini G; Moccia F
    J Cell Physiol; 2019 Apr; 234(4):4540-4562. PubMed ID: 30191989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges.
    Kurata H; Gentry PR; Kokubo M; Cho HP; Bridges TM; Niswender CM; Byers FW; Wood MR; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2015 Feb; 25(3):690-4. PubMed ID: 25542588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.